Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
January 27th, 2018
15.1K views
This paper aims to describe the interfollicular autologous platelet-rich plasma injections (0.20 mL x cm2) in the scalp of 23 patients affected by androgenetic alopecia at a depth of 5 mm using a medical injector gun equipped with a 30 gauge needle, in three sessions.
Overview
This study investigates the effects of interfollicular autologous platelet-rich plasma (PRP) injections in patients with androgenetic alopecia. A total of 23 patients received PRP injections at a depth of 5 mm using a medical injector gun across three sessions.
Key Study Components
Area of Science
- Neuroscience
- Regenerative Medicine
- Dermatology
Background
- Androgenetic alopecia is a common form of hair loss.
- Platelet-rich plasma is derived from the patient's own blood.
- PRP is believed to promote hair growth through various growth factors.
- Controlled injection techniques may enhance the efficacy of PRP treatments.
Purpose of Study
- To evaluate the effectiveness of PRP injections in treating androgenetic alopecia.
- To assess the optimal injection technique for delivering PRP.
- To document patient outcomes following treatment.
Methods Used
- Preparation of autologous not-activated PRP from patient blood.
- Centrifugation of blood to separate PRP from platelet-poor plasma.
- Use of a medical injector gun for precise delivery of PRP.
- Administration of PRP injections in three separate sessions.
Main Results
- Successful preparation of PRP from patient blood samples.
- Positive patient responses observed post-treatment.
- Controlled injection technique demonstrated effective delivery.
- Potential for PRP as a viable treatment option for hair loss.
Conclusions
- Interfollicular PRP injections may benefit patients with androgenetic alopecia.
- Further studies are needed to confirm long-term efficacy.
- Controlled injection methods enhance treatment outcomes.
Frequently Asked Questions
What is platelet-rich plasma?
Platelet-rich plasma (PRP) is a concentration of platelets derived from the patient's own blood, used to promote healing and regeneration.
How is PRP prepared?
PRP is prepared by drawing blood from the patient and centrifuging it to separate the platelets from other blood components.
What conditions can PRP treat?
PRP is commonly used for hair loss, joint pain, and skin rejuvenation.
How many sessions are required for PRP treatment?
The number of sessions can vary, but this study involved three sessions for optimal results.
Are there any side effects of PRP injections?
Side effects are generally minimal, but may include swelling, bruising, or discomfort at the injection site.
How long does it take to see results from PRP treatment?
Results can vary, but many patients begin to see improvements within a few months after treatment.
Executive Industry Relevance
This study demonstrates a standardized, mechanically controlled approach to autologous platelet-rich plasma (PRP) delivery for androgenetic alopecia, addressing variability in manual injection techniques. The method supports target validation in regenerative dermatology by enabling reproducible, depth-controlled interfollicular administration of bioactive factors. Such precision enhances predictive confidence in preclinical and early clinical evaluation of PRP-based hair regeneration strategies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of PRP’s mechanistic role in hair follicle stimulation through controlled, localized delivery.
- Operational Value: Reduces procedural variability, supporting consistent target engagement across preclinical models.
Screening & Assay Development
- Scientific Value: Provides a standardized injection protocol for evaluating PRP dose-response in ex vivo or organotypic scalp models.
- Operational Value: Facilitates assay reproducibility by defining precise volume (0.2 mL/cm²) and depth (5 mm) parameters.
Translational & Preclinical Research
- Scientific Value: Supports disease-relevant testing in androgenetic alopecia models by mimicking clinically relevant delivery parameters.
- Operational Value: Enables scalable, GMP-adjacent workflow development for autologous biologics in dermatology.
Pipeline & Workflow Integration
The method fits within the discovery-to-translational continuum for regenerative therapies, particularly in early validation of autologous biologics for dermatological indications.
- Discovery Biology: Supports hypothesis testing on PRP-mediated follicular activation via standardized delivery.
- Screening: Enables reproducible compound or biologic evaluation in hair follicle assays through controlled microinjection.
- Analytics: Generates quantitative endpoints such as hair count and density for objective outcome assessment.
- Translational Research: Bridges preclinical findings to clinical application via clinically translatable injection depth and volume.
- Enterprise Reuse: Establishes a platform-compatible injection protocol adaptable to other autologous biologics in dermatology.
Operational & Enterprise Impact
- Scientific Value: Enhances target validation confidence by minimizing delivery-related noise in mechanistic studies.
- Operational Value: Improves standardization and scalability of autologous biologic administration in outpatient settings.
- Strategic Value: Supports go/no-go decisions by reducing biological variability in early efficacy signals.
- Portfolio Impact: Enables risk-adjusted prioritization of PRP and similar regenerative candidates through consistent delivery metrics.
Implementation Considerations
- Requires expertise in autologous blood handling and PRP preparation under aseptic conditions.
- Depends on access to centrifuge and platelet-selective light separation technology.
- Necessitates standardization across sites for injection depth, volume, and device calibration.
- Must account for variability in patient-specific platelet yield and activation state.
- Limited to interfollicular delivery; does not address intra-follicular or topical alternative routes.
Biopharma FAQs
Why does controlled injection depth matter for PRP delivery in alopecia studies?
Controlled injection at 5 mm depth ensures consistent delivery to the dermal papilla region, where hair follicle stem cells reside. This precision reduces variability in target engagement across patients and supports reproducible assessment of PRP’s biological activity in preclinical and clinical evaluations.
How does mechanical injection improve reproducibility compared to manual methods in PRP studies?
Mechanical injection via a medical injector gun standardizes volume (0.2 mL/cm²) and depth, eliminating operator-dependent variability. This consistency enhances data reliability in target validation studies by ensuring uniform biologic delivery across treatment sessions and subjects.
What quantitative outcomes enable assessment of PRP efficacy in hair regeneration studies?
Higher hair count and increased density serve as primary quantitative endpoints to evaluate PRP-induced follicular activation. These metrics, measured post-treatment, provide objective readouts for assessing biological activity and supporting go/no-go decisions in regenerative therapeutic development.
Why are repeated treatment sessions necessary to assess PRP’s effect on hair follicles?
Three treatment sessions at 30-day intervals allow for cumulative biological effect assessment, reflecting the sustained signaling needed for follicular stimulation. This regimen supports evaluation of PRP’s role in promoting anagen phase transition and mitigating telogen prolongation in androgenetic alopecia models.
What analytical capabilities are required to validate PRP preparation before clinical use?
Validation requires confirmation of platelet concentration via hematologic analysis and separation efficiency using light-selector or similar technology. These capabilities ensure autologous PRP meets quality thresholds for bioactive factor content, supporting reliable target engagement in mechanistic and translational studies.
